Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of GeranylGeranylAcetone in heart failure with preserved ejection fraction
2022-000655-36Phase 2Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of teprenone in heart failure with preserved ejection fraction (HFpEF), sponsored by Amsterdam University Medical Center. Started Mar 2023; status: completed.
02
Drugs
teprenone
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on 2022-000655-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000655-36.